...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Embargo

BDAZ - From the information gleaned at the 23 Feb Broker meeting http://agoracom.com/ir/ZenithEpigenetics/forums/discussion/topics/686621-broker-meeting-23-feb/messages/2140189#message Zenith had at least one patient that was on the drug for 7 months at that time. There should be something learned from that to talk about. These were apparently pretty sick patients that were being recruited for this trial.

tada

Share
New Message
Please login to post a reply